Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Neurology"
DOI: 10.1111/ene.14096
Abstract: We hypothesized that combining intravenous immunoglobulin (IVIg) and intravenous methylprednisolone (IVMP) leads to more frequent remission compared with IVIg alone while maintaining the fast efficacy of IVIg. In this uncontrolled pilot study, we evaluated remission,…
read more here.
Keywords:
intravenous immunoglobulin;
inflammatory demyelinating;
pilot study;
chronic inflammatory ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Chemotherapy"
DOI: 10.1159/000520205
Abstract: Acute myeloid leukemia (AML) is the most common leukemia in adults. In spite of the most recent discoveries about the molecular landscape of this disease, the treatment of elderly and unfit young patients continues to…
read more here.
Keywords:
intensive induction;
young patient;
induction treatment;
npm1mut aml ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Lupus"
DOI: 10.1177/09612033221122148
Abstract: Aim The safety of multitarget treatments is of concern. This study aimed to evaluate the effectiveness and safety of multitarget therapy as an induction treatment for lupus nephritis in comparison with monotherapy. Methods This study…
read more here.
Keywords:
mmf;
group;
monotherapy;
induction treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Lupus"
DOI: 10.1177/09612033221149874
Abstract: Background For active proliferative lupus nephritis (LN), intravenous cyclophosphamide (IVCYC) is a standard therapy whereby mycophenolate mofetil (MMF) is less effective than IVCYC, according to the clinical trials in non-Asians. In this observational study, the…
read more here.
Keywords:
lupus nephritis;
value;
induction treatment;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1137629
Abstract: Anti-thymocyte/lymphocyte globulins (ATGs/ALGs) are immunosuppressive drugs used in induction therapies to prevent acute rejection in solid organ transplantation. Because of animal origin, ATGs/ALGs contain highly immunogenic carbohydrate xenoantigens eliciting antibodies that are associated with subclinical…
read more here.
Keywords:
organ transplantation;
lymphocyte;
transplantation;
induction treatment ... See more keywords